NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Beta Amyloid PET/CT in Various Aβ-Related Disease

RecruitingN/A

Sponsor: Tianjin Medical University

Conditions: Amyloid, Beta-Amyloid, Neurodegenerative Diseases

Interventions: 18F-92/AV45, 11C-PIB

Countries: China

To evaluate the potential usefulness of 18F-92/AV45, 11C-PIB positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various Tau-related disease patients.

Eligibility overview

Sex: ALL

Age: 18 Years to 80 Years

Healthy volunteers: Yes

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

\- (i) adult patients (aged 18 years or order); (ii) patients with suspected or new diagnosed or previously treated malignant tumors (supporting evidence may include MRI, CT, tumor markers and pathology report); (iii) patients who had scheduled Aβ PET/CT scan; (iv) patients who were able to provide informed consent (signed by participant, parent or legal representative) and assent according to the guidelines of the Clinical Research Ethics Committee.

Exclusion Criteria:

\- (i) patients with non-malignant lesions; (ii) patients with pregnancy; (iii) the inability or unwillingness of the research participant, parent or legal representative to provide written informed consent.

Locations (4)

Hefei, Anhui, China
Beijing, Beijing Municipality, China
Qingdao, Shandong, China
Tianjin, Tianjin Municipality, China